Nguyen, Liem Thanh
Nguyen, Phuong Mai
Nguyen, Hoang-Phuong
Bui, Hau Thi
Dao, Lan Thi Mai
Van Pham, Minh
Hoang, Chi Khanh
Nguyen, Phuong Thi
Nguyen, Thao Thi Phuong
Nguyen, Anh Thi Phuong
Hoang, Van Thi
Bui, Hoa Thi Phuong
Vuong, Ngan Kim
Van Ngo, Doan
Funding for this research was provided by:
Vingroup Joint Stock Company (ISC.19.50)
Article History
Received: 19 December 2024
Accepted: 19 May 2025
First Online: 30 May 2025
Declarations
:
: The study was approved by the National Ethics Committee of the Vietnam Ministry of Health, with approval number 120/CN-HDDD. Title of the approved project: “Autologous Bone Marrow Mononuclear Cell Transplantation Combined with Educational Intervention for Autism Spectrum Disorders (ASD): A Phase II Randomized Controlled Trial”; Name of the institutional approval committee: The National Ethics Committee of the Vietnam Ministry of Health (Hanoi, Vietnam); Approval number: 120/CN-HDDD; Date of approval: November 05, 2021. The patients’ guardians or legally authorized representatives provided written informed consent for their participation in the study and the use of samples. The consent explicitly included permission to use patient identifiers, such as age and sex, for publication purposes. All treatments, including clinical examinations, laboratory tests, brain MRI, EEG, genetic tests, cell collection, cell processing, cell administration, hospital stay fees, and educational interventions, were provided free of charge to the participants and their families.
: Not applicable.
: The authors declare that they have no competing interests.